Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms JH 002, JH-002, JH-02 + [3] |
Target |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators), Ionising radiation emitters |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Prostate Carcinoma | Phase 2 | CN | 08 Dec 2023 | |
PSMA-Positive Castration-Resistant Prostatic Cancer | IND Approval | CN | 24 Jul 2023 |